iNKT Cells as Immunotherapeutic Agents in EBV-driven Lymphomagenesis

Last updated 29th Jun 2017
Follow pinboard


A pinboard by Akshat Sharma

Graduate Student, University of Wisconsin-Madison


iNKT cells are effective against EBV-driven lymphomas in humanised mice.

NSG "humanised' mice are a powerful tool to model human-specific diseases and cancers, such as EBV-driven lymphoma. The interactions between the immune system and transformed cells remain poorl...